The market seems to be overlooking AMBP’s potential, with its stock trading significantly below its DCF value. The Forward P/E of 11.89 suggests a more reasonable valuation compared to its astronomical current P/E, hinting at expected earnings growth. However, the Altman Z-score of 1.18 raises red flags about financial distress, and the negative Price/Book ratio is a glaring anomaly. Despite these concerns, the Earnings Yield is a mere 0.46%, indicating the stock might not be generating sufficient returns relative to its price.